fingolimod hydrochloride has been researched along with vatalanib in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 276 | 42 | 98 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | vatalanib (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.4577 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.2013 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.73 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.1192 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.1475 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.378 | |
| Vascular endothelial growth factor receptor 2 | Danio rerio (zebrafish) | 0.49 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billy, E; Butler, J; Hla, T; LaMontagne, K; Liau, G; Littlewood-Evans, A; O'Reilly, T; Probst, B; Sanchez, T; Schnell, C; Theuer, A; Wood, A; Wood, J; Wyder, L | 1 |
1 other study(ies) available for fingolimod hydrochloride and vatalanib
| Article | Year |
|---|---|
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
Topics: Animals; Calcium; Cell Growth Processes; Cell Movement; Cornea; Endothelial Cells; Female; Fingolimod Hydrochloride; Humans; Melanoma, Experimental; Mice; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Phthalazines; Propylene Glycols; Pyridines; Receptors, Lysosphingolipid; Sphingosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2006 |